Task: Answer the multiple-choice question.
Question: Which drug exhibits a -19.254% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] Cc1ccc(NC(=O)CCC(=O)c2cc(C)sc2C)nc1
[b] CCc1ccc(-n2c(SCC(=O)Nc3ccc(C(=O)O)cc3)nnc2-c2ccncc2)cc1
[c] COc1ccc(-n2ncc3c(NCc4ccco4)ncnc32)cc1
Answer: a. Cc1ccc(NC(=O)CCC(=O)c2cc(C)sc2C)nc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)CCC(=O)c2cc(C)sc2C)nc1
Cc1ccc(NC(=O)CCC(=O)c2cc(C)sc2C)nc1
4-(2,5-dimethylthiophen-3-yl)-N-(5-methylpyridin-2-yl)-4-oxobutanamide